Navigation Links
Halozyme to Host First Quarter 2012 Financial Results Conference Call
Date:4/30/2012

SAN DIEGO, April 30, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the first quarter 2012 on Monday, May 7, 2012 at 4:30 p.m. ET/1:30 p.m. PT. Gregory I. Frost, President and Chief Executive Officer, will lead the call. On the same date post-market, Halozyme will release financial results for the first quarter 2012.

(Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

The call will be webcast live through the "Investors" section of Halozyme's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to www.halozyme.com approximately fifteen minutes prior to the call to register, download, and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (877) 407-8037 (domestic callers) or (201) 689-8037 (international callers). A telephone replay will be available shortly after the call by dialing (877) 660-6853 (domestic callers) or (201) 612-7415 (international callers) using account number 367 and replay ID number 393124.

About Halozyme
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets HYLENEX® recombinant (hyaluronidase human injection)
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20)
2. Halozyme Therapeutics to Present at the CITI 2012 Global Healthcare Conference
3. Halozyme Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Stock
4. Halozyme Announces Proposed Public Offering of Common Stock
5. ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
6. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
7. Halozyme Therapeutics to Present Data on PEGPH20 at the Upcoming 2011 EORTC-NCI-ASCO Annual Meeting
8. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
9. Halozyme Begins Randomized, Controlled Clinical Trial with PEGPH20 in Patients with Advanced Pancreatic Cancer
10. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
11. Halozyme Therapeutics to Present at Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Medical Systems (NYSE: VAR ) today is ... the third quarter of fiscal year 2014.  Net earnings ... due to an approximately $8 million impairment charge related ... Augmenix, a privately-held company developing minimally invasive hydrogels for ... third quarter of fiscal year 2014, up 3 percent ...
(Date:7/23/2014)... , July 23, 2014 Research and ... "Sensor Market in Consumer Healthcare by Application, Sensor Type ... 2013 - 2020" report to their offering. ... has been an increasing momentum for consumer healthcare monitoring ... sophistication. The consumer healthcare will lessen the healthcare cost ...
(Date:7/23/2014)... July 23, 2014 Pharmavite LLC announced that ... customer officer effective immediately. Toll recently served as Pharmavite,s ... marketing, category management, private label and sales administration in ... new global role, Toll will expand his responsibilities to ... "Toll,s appointment to chief customer officer is ...
Breaking Medicine Technology:Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 7Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 8Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 9Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 10Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 2Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 3
... ROCKVILLE, Md., July 6 A procedure that sends targeted ... to treat a common type of irregular heartbeat, but little ... methods and circumstances for applying it, according to a new ... , , The report examines the use of a ...
... The Netherlands, July 6 Three new small and,medium ... - have joined public-private partnership TI Pharma by,participating in ... diseases, have a total budget of nearly 6 million ... formed by Syncom, Synvolux Therapeutics, and,University Medical Center Groningen, ...
Cached Medicine Technology:New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation 2New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation 3New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects 2
(Date:7/24/2014)... read the declaration of contents if you need to know ... this you need to be a highly skilled chemist or ... directly into the molecular structure of the various substances. Christian ... both, as he has developed a method that allows him ... , The ,Fingerprints, of a Substance , The technique ...
(Date:7/24/2014)... News) -- A growing number of U.S. teens are ... muscles and athletic ability, a new study finds. ... hGH jumped to 11 percent in 2013 -- more ... new survey from the Partnership for Drug-Free Kids revealed. ... tighter regulation and oversight of performance-enhancing substances and other ...
(Date:7/24/2014)... July 24, 2014 Recently, Stwd.co.uk, a professional ... its product line by adding many new designs of ... outfits in the new collection come with big discounts. According ... a special offer on all these fashionable items. They are ... a pink V-neck strapless beading prom dress was previously priced ...
(Date:7/24/2014)... Hayes, Inc. ( http://www.hayesinc.com ), a leader ... evidence, is pleased to announce that Dee Donatelli, Senior ... at the AHRMM14 Conference in Orlando, FL, ... value analysis who also serves as the current President ... will facilitate and participate in two preconference sessions on ...
(Date:7/24/2014)... 24, 2014 Catholic Health Partners (CHP), ... Partners, has changed its name to Mercy Health. The ... to one unified team, focused on high-quality care, increased ... largest health system and fourth-largest employer. , “Our new ... are working together to improve the health of the ...
Breaking Medicine News(10 mins):Health News:Chemist develops X-ray vision for quality assurance 2Health News:Chemist develops X-ray vision for quality assurance 3Health News:Dangerous Use of Growth Hormone Surges Among U.S. Teens 2Health News:Dangerous Use of Growth Hormone Surges Among U.S. Teens 3Health News:Dangerous Use of Growth Hormone Surges Among U.S. Teens 4Health News:Dangerous Use of Growth Hormone Surges Among U.S. Teens 5Health News:Cheap Wedding Dresses Are Offered by Stwd.co.uk at Low Prices 2Health News:Hayes, Inc. Senior Vice President to Speak at AHRMM14 Conference 2Health News:Hayes, Inc. Senior Vice President to Speak at AHRMM14 Conference 3Health News:HMHP’s Parent, Catholic Health Partners, Changes Name to Mercy Health 2Health News:HMHP’s Parent, Catholic Health Partners, Changes Name to Mercy Health 3Health News:HMHP’s Parent, Catholic Health Partners, Changes Name to Mercy Health 4
... 10 (HealthDay News) -- People who suffer sudden cardiac arrest ... help bystanders assess victims and begin CPR immediately, says a ... of its main goals is to increase how often bystanders ... to arms," statement lead author E. Brooke Lerner, an associate ...
... West Orange, NJ. January 10, 2012. Kessler Foundation ... for Creative Technologies will collaborate on clinical research ... motor rehabilitation research. The goal, according to USC,s ... Reality research group, is to conduct research to ...
... the results of a new study published in the ... American College of Surgeons , many early-stage breast cancer ... meaningfully involved in treatment discussions or asked their preferences ... study,s investigators determined that there is a need for ...
... of Annals takes an up-close look at multimorbidity, ... individual, a phenomenon that is growing at an alarming rate ... by the year 2020, 25 percent of the American population ... managing these conditions will reach $1.07 trillion. In fact, more ...
... Reporter , MONDAY, Jan. 9 (HealthDay News) -- There really ... that finds losing a loved one can increase the risk ... other,s death, heart attack risk was 21 times higher than ... heart attack patients. And within the first week after death, ...
... study by researchers at the Johns Hopkins Center for Gun ... were subsequently linked to crime sold by Badger Guns & ... measures likely to reduce the risks gun dealers face if ... to examine the impact of these amendments on the diversion ...
Cached Medicine News:Health News:Heart Experts Make Boosting Bystander CPR a Priority 2Health News:Kessler Foundation and USC collaborate on clinical virtual reality for disability research 2Health News:Early-stage breast cancer patients lack knowledge; may not receive treatment they prefer 2Health News:Early-stage breast cancer patients lack knowledge; may not receive treatment they prefer 3Health News:January/February 2012 Annals of Family Medicine 2Health News:January/February 2012 Annals of Family Medicine 3Health News:January/February 2012 Annals of Family Medicine 4Health News:January/February 2012 Annals of Family Medicine 5Health News:January/February 2012 Annals of Family Medicine 6Health News:January/February 2012 Annals of Family Medicine 7Health News:January/February 2012 Annals of Family Medicine 8Health News:January/February 2012 Annals of Family Medicine 9Health News:Grief Is a Real Heartbreaker, Study Finds 2Health News:Grief Is a Real Heartbreaker, Study Finds 3Health News:Study finds federal amendments increased gun sales diverted to criminals 2Health News:Study finds federal amendments increased gun sales diverted to criminals 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: